Literature DB >> 15632388

Risks and benefits of beta-blockade.

Stephen R Workman.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15632388      PMCID： PMC543925          DOI： 10.1503/cmaj.1041425

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?

Authors:  P J Devereaux; Salim Yusuf; Homer Yang; Peter T-L Choi; Gordon H Guyatt
Journal:  CMAJ       Date:  2004-08-03       Impact factor: 8.262

Review 2.  The international variation in breast cancer rates: an epidemiological assessment.

Authors:  B E Henderson; L Bernstein
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

Review 3.  Epidemiology of pulmonary embolism.

Authors:  S Z Goldhaber
Journal:  Semin Vasc Med       Date:  2001-11

4.  Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators.

Authors:  M A Mittleman; M Maclure; G H Tofler; J B Sherwood; R J Goldberg; J E Muller
Journal:  N Engl J Med       Date:  1993-12-02       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.